EU
OMass Therapeutics
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics for rare diseases and immunological conditions using its OdyssION platform.
omass.com
1
active jobs
View all company jobs
Hybrid 1
About the company
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics. Its work focuses on rare diseases and immunological conditions, with programmes aimed at targets such as membrane proteins, intracellular complexes, solute carriers and GPCRs. The company describes its OdyssION platform as combining novel biochemistry, native mass spectrometry and custom chemistry.
Candidate highlights
- Biotechnology company developing small-molecule therapeutics.
- Focuses on rare diseases and immunological conditions.
- Uses the OdyssION technology platform for drug discovery.
- Economic sector
- Biotechnology
- Commercial focus
- Drug discovery and development of small-molecule therapeutics
- Headquarters
- Oxford
Current openings
1
active jobs
- Main cities
- Oxford (1)
- Workplace
- Hybrid (1)
- Employment
- Full time (1)